ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Pet Pain Reliever Market Outlook, In‑Depth Analysis & Forecast to 2031
Published Date: November 2025
|
Report Code: QYRE-Auto-9F17406
Home | Market Reports | Pets & Animals| Animal Products & Services| Pet Food & Supplies
Global Pet Pain Reliever Market Research Report 2024
BUY CHAPTERS

Global Pet Pain Reliever Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-9F17406
Report
November 2025
Pages:163
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Tianjin Ringpu Bio-Technology
Bayer
Zoetis Inc
Huadong Medicine
Elanco
Vetoquinol
Nutra Pharma
Medico Herbs
Dechra Pharmaceuticals
Norbrook Laboratories
Dog Pain Away
MSD Animal Health UK

Pet Pain Reliever Market

The global Pet Pain Reliever market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
From a downstream perspective, Dog accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Pet Pain Reliever leading manufacturers including Tianjin Ringpu Bio-technology, Boehringer Ingelheim, Bayer AG, Zoetis, Huadong Medicine, Elanco, Nutramax Laboratories, Vetoquinol, Nutra Pharma, Dog Pain Away, etc., dominate supply; the top five capture approximately % of global revenue, with Tianjin Ringpu Bio-technology leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Pet Pain Reliever market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation

Scope of Pet Pain Reliever Market Report

Report Metric Details
Report Name Pet Pain Reliever Market
Segment by Type
  • Alpha2 Agonist
  • NSAIDs
  • Opioids
  • Other
Segment by Application
  • Dog
  • Cat
  • Other
Sales by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Tianjin Ringpu Bio-technology, Boehringer Ingelheim, Bayer AG, Zoetis, Huadong Medicine, Elanco, Nutramax Laboratories, Vetoquinol, Nutra Pharma, Dog Pain Away, Medico Herbs, Dechra Pharmaceuticals, Norbrook Laboratories, MSD Animal Health UK
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the Pet Pain Reliever study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
  • Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
  • Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
  • Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
  • Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
  • Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
  • Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
  • Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
  • Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
  • Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
  • Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
  • Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
  • Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 15: Actionable conclusions and strategic recommendations.
  • Why This Report:
  • Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
  • Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
  • Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
  • Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
  • Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
  • Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the Pet Pain Reliever Market report?

Ans: The main players in the Pet Pain Reliever Market are Tianjin Ringpu Bio-technology, Boehringer Ingelheim, Bayer AG, Zoetis, Huadong Medicine, Elanco, Nutramax Laboratories, Vetoquinol, Nutra Pharma, Dog Pain Away, Medico Herbs, Dechra Pharmaceuticals, Norbrook Laboratories, MSD Animal Health UK

What are the Application segmentation covered in the Pet Pain Reliever Market report?

Ans: The Applications covered in the Pet Pain Reliever Market report are Dog, Cat, Other

What are the Type segmentation covered in the Pet Pain Reliever Market report?

Ans: The Types covered in the Pet Pain Reliever Market report are Alpha2 Agonist, NSAIDs, Opioids, Other

1 Study Coverage
1.1 Introduction to Pet Pain Reliever: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Pet Pain Reliever Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Alpha2 Agonist
1.2.3 NSAIDs
1.2.4 Opioids
1.2.5 Other
1.3 Market Segmentation by Application
1.3.1 Global Pet Pain Reliever Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Dog
1.3.3 Cat
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Pet Pain Reliever Revenue Estimates and Forecasts 2020-2031
2.2 Global Pet Pain Reliever Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Pet Pain Reliever Sales Estimates and Forecasts 2020-2031
2.4 Global Pet Pain Reliever Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Pet Pain Reliever Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Pet Pain Reliever Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 Alpha2 Agonist Market Size by Manufacturers
3.5.2 NSAIDs Market Size by Manufacturers
3.5.3 Opioids Market Size by Manufacturers
3.5.4 Other Market Size by Manufacturers
3.6 Global Pet Pain Reliever Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Pet Pain Reliever Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Pet Pain Reliever Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Pet Pain Reliever Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Pet Pain Reliever Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Pet Pain Reliever Sales and Revenue by Type (2020-2031)
6.4 North America Pet Pain Reliever Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Pet Pain Reliever Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Pet Pain Reliever Sales and Revenue by Type (2020-2031)
7.4 Europe Pet Pain Reliever Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Pet Pain Reliever Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Pet Pain Reliever Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Pet Pain Reliever Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Pet Pain Reliever Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Pet Pain Reliever Sales and Revenue by Type (2020-2031)
9.4 Central and South America Pet Pain Reliever Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Pet Pain Reliever Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Pet Pain Reliever Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Pet Pain Reliever Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Pet Pain Reliever Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Tianjin Ringpu Bio-technology
11.1.1 Tianjin Ringpu Bio-technology Corporation Information
11.1.2 Tianjin Ringpu Bio-technology Business Overview
11.1.3 Tianjin Ringpu Bio-technology Pet Pain Reliever Product Models, Descriptions and Specifications
11.1.4 Tianjin Ringpu Bio-technology Pet Pain Reliever Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 Tianjin Ringpu Bio-technology Pet Pain Reliever Sales by Product in 2024
11.1.6 Tianjin Ringpu Bio-technology Pet Pain Reliever Sales by Application in 2024
11.1.7 Tianjin Ringpu Bio-technology Pet Pain Reliever Sales by Geographic Area in 2024
11.1.8 Tianjin Ringpu Bio-technology Pet Pain Reliever SWOT Analysis
11.1.9 Tianjin Ringpu Bio-technology Recent Developments
11.2 Boehringer Ingelheim
11.2.1 Boehringer Ingelheim Corporation Information
11.2.2 Boehringer Ingelheim Business Overview
11.2.3 Boehringer Ingelheim Pet Pain Reliever Product Models, Descriptions and Specifications
11.2.4 Boehringer Ingelheim Pet Pain Reliever Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 Boehringer Ingelheim Pet Pain Reliever Sales by Product in 2024
11.2.6 Boehringer Ingelheim Pet Pain Reliever Sales by Application in 2024
11.2.7 Boehringer Ingelheim Pet Pain Reliever Sales by Geographic Area in 2024
11.2.8 Boehringer Ingelheim Pet Pain Reliever SWOT Analysis
11.2.9 Boehringer Ingelheim Recent Developments
11.3 Bayer AG
11.3.1 Bayer AG Corporation Information
11.3.2 Bayer AG Business Overview
11.3.3 Bayer AG Pet Pain Reliever Product Models, Descriptions and Specifications
11.3.4 Bayer AG Pet Pain Reliever Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 Bayer AG Pet Pain Reliever Sales by Product in 2024
11.3.6 Bayer AG Pet Pain Reliever Sales by Application in 2024
11.3.7 Bayer AG Pet Pain Reliever Sales by Geographic Area in 2024
11.3.8 Bayer AG Pet Pain Reliever SWOT Analysis
11.3.9 Bayer AG Recent Developments
11.4 Zoetis
11.4.1 Zoetis Corporation Information
11.4.2 Zoetis Business Overview
11.4.3 Zoetis Pet Pain Reliever Product Models, Descriptions and Specifications
11.4.4 Zoetis Pet Pain Reliever Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 Zoetis Pet Pain Reliever Sales by Product in 2024
11.4.6 Zoetis Pet Pain Reliever Sales by Application in 2024
11.4.7 Zoetis Pet Pain Reliever Sales by Geographic Area in 2024
11.4.8 Zoetis Pet Pain Reliever SWOT Analysis
11.4.9 Zoetis Recent Developments
11.5 Huadong Medicine
11.5.1 Huadong Medicine Corporation Information
11.5.2 Huadong Medicine Business Overview
11.5.3 Huadong Medicine Pet Pain Reliever Product Models, Descriptions and Specifications
11.5.4 Huadong Medicine Pet Pain Reliever Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 Huadong Medicine Pet Pain Reliever Sales by Product in 2024
11.5.6 Huadong Medicine Pet Pain Reliever Sales by Application in 2024
11.5.7 Huadong Medicine Pet Pain Reliever Sales by Geographic Area in 2024
11.5.8 Huadong Medicine Pet Pain Reliever SWOT Analysis
11.5.9 Huadong Medicine Recent Developments
11.6 Elanco
11.6.1 Elanco Corporation Information
11.6.2 Elanco Business Overview
11.6.3 Elanco Pet Pain Reliever Product Models, Descriptions and Specifications
11.6.4 Elanco Pet Pain Reliever Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 Elanco Recent Developments
11.7 Nutramax Laboratories
11.7.1 Nutramax Laboratories Corporation Information
11.7.2 Nutramax Laboratories Business Overview
11.7.3 Nutramax Laboratories Pet Pain Reliever Product Models, Descriptions and Specifications
11.7.4 Nutramax Laboratories Pet Pain Reliever Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 Nutramax Laboratories Recent Developments
11.8 Vetoquinol
11.8.1 Vetoquinol Corporation Information
11.8.2 Vetoquinol Business Overview
11.8.3 Vetoquinol Pet Pain Reliever Product Models, Descriptions and Specifications
11.8.4 Vetoquinol Pet Pain Reliever Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.5 Vetoquinol Recent Developments
11.9 Nutra Pharma
11.9.1 Nutra Pharma Corporation Information
11.9.2 Nutra Pharma Business Overview
11.9.3 Nutra Pharma Pet Pain Reliever Product Models, Descriptions and Specifications
11.9.4 Nutra Pharma Pet Pain Reliever Sales, Price, Revenue and Gross Margin (2020-2025)
11.9.5 Nutra Pharma Recent Developments
11.10 Dog Pain Away
11.10.1 Dog Pain Away Corporation Information
11.10.2 Dog Pain Away Business Overview
11.10.3 Dog Pain Away Pet Pain Reliever Product Models, Descriptions and Specifications
11.10.4 Dog Pain Away Pet Pain Reliever Sales, Price, Revenue and Gross Margin (2020-2025)
11.10.5 Dog Pain Away Recent Developments
11.11 Medico Herbs
11.11.1 Medico Herbs Corporation Information
11.11.2 Medico Herbs Business Overview
11.11.3 Medico Herbs Pet Pain Reliever Product Models, Descriptions and Specifications
11.11.4 Medico Herbs Pet Pain Reliever Sales, Price, Revenue and Gross Margin (2020-2025)
11.11.5 Medico Herbs Recent Developments
11.12 Dechra Pharmaceuticals
11.12.1 Dechra Pharmaceuticals Corporation Information
11.12.2 Dechra Pharmaceuticals Business Overview
11.12.3 Dechra Pharmaceuticals Pet Pain Reliever Product Models, Descriptions and Specifications
11.12.4 Dechra Pharmaceuticals Pet Pain Reliever Sales, Price, Revenue and Gross Margin (2020-2025)
11.12.5 Dechra Pharmaceuticals Recent Developments
11.13 Norbrook Laboratories
11.13.1 Norbrook Laboratories Corporation Information
11.13.2 Norbrook Laboratories Business Overview
11.13.3 Norbrook Laboratories Pet Pain Reliever Product Models, Descriptions and Specifications
11.13.4 Norbrook Laboratories Pet Pain Reliever Sales, Price, Revenue and Gross Margin (2020-2025)
11.13.5 Norbrook Laboratories Recent Developments
11.14 MSD Animal Health UK
11.14.1 MSD Animal Health UK Corporation Information
11.14.2 MSD Animal Health UK Business Overview
11.14.3 MSD Animal Health UK Pet Pain Reliever Product Models, Descriptions and Specifications
11.14.4 MSD Animal Health UK Pet Pain Reliever Sales, Price, Revenue and Gross Margin (2020-2025)
11.14.5 MSD Animal Health UK Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Pet Pain Reliever Industry Chain
12.2 Pet Pain Reliever Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Pet Pain Reliever Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Pet Pain Reliever Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Pet Pain Reliever Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Pet Pain Reliever Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
FEATURED COMPANIES
Tianjin Ringpu Bio-Technology
Bayer
Zoetis Inc
Huadong Medicine
Elanco
Vetoquinol
Nutra Pharma
Medico Herbs
Dechra Pharmaceuticals
Norbrook Laboratories
Dog Pain Away
MSD Animal Health UK
List of Tables
 Table 1. Global Pet Pain Reliever Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global Pet Pain Reliever Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global Pet Pain Reliever Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global Pet Pain Reliever Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Pet Pain Reliever Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Global Pet Pain Reliever Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Units)
 Table 7. Global Pet Pain Reliever Sales by Region (2020-2025) & (Units)
 Table 8. Global Pet Pain Reliever Sales by Region (2026-2031) & (Units)
 Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 10. Global Pet Pain Reliever Sales by Manufacturers (2020-2025) & (Units)
 Table 11. Global Pet Pain Reliever Sales Share by Manufacturers (2020-2025)
 Table 12. Global Pet Pain Reliever Revenue by Manufacturers (2020-2025) & (US$ Million)
 Table 13. Global Pet Pain Reliever Revenue Market Share by Manufacturers (2020-2025)
 Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 15. Global Pet Pain Reliever by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pet Pain Reliever as of 2024)
 Table 16. Global Pet Pain Reliever Average Gross Margin (%) by Manufacturer (2020 VS 2024)
 Table 17. Global Pet Pain Reliever Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)
 Table 18. Key Manufacturers Pet Pain Reliever Manufacturing Base and Headquarters
 Table 19. Global Pet Pain Reliever Market Concentration Ratio (CR5 and HHI)
 Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 22. Global Pet Pain Reliever Sales by Type (2020-2025) & (Units)
 Table 23. Global Pet Pain Reliever Sales by Type (2026-2031) & (Units)
 Table 24. Global Pet Pain Reliever Revenue by Type (2020-2025) & (US$ Million)
 Table 25. Global Pet Pain Reliever Revenue by Type (2026-2031) & (US$ Million)
 Table 26. Global Pet Pain Reliever ASP by Type (2020-2031) & (US$/Unit)
 Table 27. Technical Specifications by Key Product Type
 Table 28. Global Pet Pain Reliever Sales by Application (2020-2025) & (Units)
 Table 29. Global Pet Pain Reliever Sales by Application (2026-2031) & (Units)
 Table 30. Pet Pain Reliever High-Growth Sectors Demand CAGR (2024-2031)
 Table 31. Global Pet Pain Reliever Revenue by Application (2020-2025) & (US$ Million)
 Table 32. Global Pet Pain Reliever Revenue by Application (2026-2031) & (US$ Million)
 Table 33. Global Pet Pain Reliever ASP by Application (2020-2031) & (US$/Unit)
 Table 34. Top Customers by Region
 Table 35. Top Customers by Application
 Table 36. North America Pet Pain Reliever Growth Accelerators and Market Barriers
 Table 37. North America Pet Pain Reliever Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 38. North America Pet Pain Reliever Sales (Units) by Country (2020 VS 2024 VS 2031)
 Table 39. Europe Pet Pain Reliever Growth Accelerators and Market Barriers
 Table 40. Europe Pet Pain Reliever Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Europe Pet Pain Reliever Sales (Units) by Country (2020 VS 2024 VS 2031)
 Table 42. Asia-Pacific Pet Pain Reliever Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 43. Asia-Pacific Pet Pain Reliever Sales (Units) by Country (2020 VS 2024 VS 2031)
 Table 44. Asia-Pacific Pet Pain Reliever Growth Accelerators and Market Barriers
 Table 45. Southeast Asia Pet Pain Reliever Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Central and South America Pet Pain Reliever Investment Opportunities and Key Challenges
 Table 47. Central and South America Pet Pain Reliever Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 48. Middle East and Africa Pet Pain Reliever Investment Opportunities and Key Challenges
 Table 49. Middle East and Africa Pet Pain Reliever Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 50. Tianjin Ringpu Bio-technology Corporation Information
 Table 51. Tianjin Ringpu Bio-technology Description and Major Businesses
 Table 52. Tianjin Ringpu Bio-technology Product Models, Descriptions and Specifications
 Table 53. Tianjin Ringpu Bio-technology Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 54. Tianjin Ringpu Bio-technology Sales Value Proportion by Product in 2024
 Table 55. Tianjin Ringpu Bio-technology Sales Value Proportion by Application in 2024
 Table 56. Tianjin Ringpu Bio-technology Sales Value Proportion by Geographic Area in 2024
 Table 57. Tianjin Ringpu Bio-technology Pet Pain Reliever SWOT Analysis
 Table 58. Tianjin Ringpu Bio-technology Recent Developments
 Table 59. Boehringer Ingelheim Corporation Information
 Table 60. Boehringer Ingelheim Description and Major Businesses
 Table 61. Boehringer Ingelheim Product Models, Descriptions and Specifications
 Table 62. Boehringer Ingelheim Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 63. Boehringer Ingelheim Sales Value Proportion by Product in 2024
 Table 64. Boehringer Ingelheim Sales Value Proportion by Application in 2024
 Table 65. Boehringer Ingelheim Sales Value Proportion by Geographic Area in 2024
 Table 66. Boehringer Ingelheim Pet Pain Reliever SWOT Analysis
 Table 67. Boehringer Ingelheim Recent Developments
 Table 68. Bayer AG Corporation Information
 Table 69. Bayer AG Description and Major Businesses
 Table 70. Bayer AG Product Models, Descriptions and Specifications
 Table 71. Bayer AG Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 72. Bayer AG Sales Value Proportion by Product in 2024
 Table 73. Bayer AG Sales Value Proportion by Application in 2024
 Table 74. Bayer AG Sales Value Proportion by Geographic Area in 2024
 Table 75. Bayer AG Pet Pain Reliever SWOT Analysis
 Table 76. Bayer AG Recent Developments
 Table 77. Zoetis Corporation Information
 Table 78. Zoetis Description and Major Businesses
 Table 79. Zoetis Product Models, Descriptions and Specifications
 Table 80. Zoetis Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 81. Zoetis Sales Value Proportion by Product in 2024
 Table 82. Zoetis Sales Value Proportion by Application in 2024
 Table 83. Zoetis Sales Value Proportion by Geographic Area in 2024
 Table 84. Zoetis Pet Pain Reliever SWOT Analysis
 Table 85. Zoetis Recent Developments
 Table 86. Huadong Medicine Corporation Information
 Table 87. Huadong Medicine Description and Major Businesses
 Table 88. Huadong Medicine Product Models, Descriptions and Specifications
 Table 89. Huadong Medicine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 90. Huadong Medicine Sales Value Proportion by Product in 2024
 Table 91. Huadong Medicine Sales Value Proportion by Application in 2024
 Table 92. Huadong Medicine Sales Value Proportion by Geographic Area in 2024
 Table 93. Huadong Medicine Pet Pain Reliever SWOT Analysis
 Table 94. Huadong Medicine Recent Developments
 Table 95. Elanco Corporation Information
 Table 96. Elanco Description and Major Businesses
 Table 97. Elanco Product Models, Descriptions and Specifications
 Table 98. Elanco Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 99. Elanco Recent Developments
 Table 100. Nutramax Laboratories Corporation Information
 Table 101. Nutramax Laboratories Description and Major Businesses
 Table 102. Nutramax Laboratories Product Models, Descriptions and Specifications
 Table 103. Nutramax Laboratories Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 104. Nutramax Laboratories Recent Developments
 Table 105. Vetoquinol Corporation Information
 Table 106. Vetoquinol Description and Major Businesses
 Table 107. Vetoquinol Product Models, Descriptions and Specifications
 Table 108. Vetoquinol Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 109. Vetoquinol Recent Developments
 Table 110. Nutra Pharma Corporation Information
 Table 111. Nutra Pharma Description and Major Businesses
 Table 112. Nutra Pharma Product Models, Descriptions and Specifications
 Table 113. Nutra Pharma Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 114. Nutra Pharma Recent Developments
 Table 115. Dog Pain Away Corporation Information
 Table 116. Dog Pain Away Description and Major Businesses
 Table 117. Dog Pain Away Product Models, Descriptions and Specifications
 Table 118. Dog Pain Away Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 119. Dog Pain Away Recent Developments
 Table 120. Medico Herbs Corporation Information
 Table 121. Medico Herbs Description and Major Businesses
 Table 122. Medico Herbs Product Models, Descriptions and Specifications
 Table 123. Medico Herbs Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 124. Medico Herbs Recent Developments
 Table 125. Dechra Pharmaceuticals Corporation Information
 Table 126. Dechra Pharmaceuticals Description and Major Businesses
 Table 127. Dechra Pharmaceuticals Product Models, Descriptions and Specifications
 Table 128. Dechra Pharmaceuticals Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 129. Dechra Pharmaceuticals Recent Developments
 Table 130. Norbrook Laboratories Corporation Information
 Table 131. Norbrook Laboratories Description and Major Businesses
 Table 132. Norbrook Laboratories Product Models, Descriptions and Specifications
 Table 133. Norbrook Laboratories Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 134. Norbrook Laboratories Recent Developments
 Table 135. MSD Animal Health UK Corporation Information
 Table 136. MSD Animal Health UK Description and Major Businesses
 Table 137. MSD Animal Health UK Product Models, Descriptions and Specifications
 Table 138. MSD Animal Health UK Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 139. MSD Animal Health UK Recent Developments
 Table 140. Key Raw Materials Distribution
 Table 141. Raw Materials Key Suppliers
 Table 142. Critical Raw Material Supplier Concentration (2024) & Risk Index
 Table 143. Milestones in Production Technology Evolution
 Table 144. Distributors List
 Table 145. Market Trends and Market Evolution
 Table 146. Market Drivers and Opportunities
 Table 147. Market Challenges, Risks, and Restraints
 Table 148. Research Programs/Design for This Report
 Table 149. Key Data Information from Secondary Sources
 Table 150. Key Data Information from Primary Sources


List of Figures
 Figure 1. Pet Pain Reliever Product Picture
 Figure 2. Global Pet Pain Reliever Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Alpha2 Agonist Product Picture
 Figure 4. NSAIDs Product Picture
 Figure 5. Opioids Product Picture
 Figure 6. Other Product Picture
 Figure 7. Global Pet Pain Reliever Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 8. Dog
 Figure 9. Cat
 Figure 10. Other
 Figure 11. Pet Pain Reliever Report Years Considered
 Figure 12. Global Pet Pain Reliever Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Pet Pain Reliever Revenue (2020-2031) & (US$ Million)
 Figure 14. Global Pet Pain Reliever Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 15. Global Pet Pain Reliever Revenue Market Share by Region (2020-2031)
 Figure 16. Global Pet Pain Reliever Sales (2020-2031) & (Units)
 Figure 17. Global Pet Pain Reliever Sales (CAGR) by Region (2020-2031) (Units)
 Figure 18. Global Pet Pain Reliever Sales Market Share by Region (2020-2031)
 Figure 19. Top 5 and Top 10 Manufacturers Pet Pain Reliever Sales Volume Market Share in 2024
 Figure 20. Global Pet Pain Reliever Revenue Market Share Ranking (2024)
 Figure 21. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 22. Alpha2 Agonist Revenue Market Share by Manufacturer in 2024
 Figure 23. NSAIDs Revenue Market Share by Manufacturer in 2024
 Figure 24. Opioids Revenue Market Share by Manufacturer in 2024
 Figure 25. Other Revenue Market Share by Manufacturer in 2024
 Figure 26. Global Pet Pain Reliever Sales Market Share by Type (2020-2031)
 Figure 27. Global Pet Pain Reliever Revenue Market Share by Type (2020-2031)
 Figure 28. Global Pet Pain Reliever Sales Market Share by Application (2020-2031)
 Figure 29. Global Pet Pain Reliever Revenue Market Share by Application (2020-2031)
 Figure 30. North America Pet Pain Reliever Sales YoY (2020-2031) & (Units)
 Figure 31. North America Pet Pain Reliever Revenue YoY (2020-2031) & (US$ Million)
 Figure 32. North America Top 5 Manufacturers Pet Pain Reliever Sales Revenue (US$ Million) in 2024
 Figure 33. North America Pet Pain Reliever Sales Volume (Units) by Type (2020- 2031)
 Figure 34. North America Pet Pain Reliever Sales Revenue (US$ Million) by Type (2020 - 2031)
 Figure 35. North America Pet Pain Reliever Sales Volume (Units) by Application (2020-2031)
 Figure 36. North America Pet Pain Reliever Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 37. US Pet Pain Reliever Revenue (2020-2031) & (US$ Million)
 Figure 38. Canada Pet Pain Reliever Revenue (2020-2031) & (US$ Million)
 Figure 39. Mexico Pet Pain Reliever Revenue (2020-2031) & (US$ Million)
 Figure 40. Europe Pet Pain Reliever Sales YoY (2020-2031) & (Units)
 Figure 41. Europe Pet Pain Reliever Revenue YoY (2020-2031) & (US$ Million)
 Figure 42. Europe Top 5 Manufacturers Pet Pain Reliever Sales Revenue (US$ Million) in 2024
 Figure 43. Europe Pet Pain Reliever Sales Volume (Units) by Type (2020-2031)
 Figure 44. Europe Pet Pain Reliever Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 45. Europe Pet Pain Reliever Sales Volume (Units) by Application (2020-2031)
 Figure 46. Europe Pet Pain Reliever Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 47. Germany Pet Pain Reliever Revenue (2020-2031) & (US$ Million)
 Figure 48. France Pet Pain Reliever Revenue (2020-2031) & (US$ Million)
 Figure 49. U.K. Pet Pain Reliever Revenue (2020-2031) & (US$ Million)
 Figure 50. Italy Pet Pain Reliever Revenue (2020-2031) & (US$ Million)
 Figure 51. Russia Pet Pain Reliever Revenue (2020-2031) & (US$ Million)
 Figure 52. Asia-Pacific Pet Pain Reliever Sales YoY (2020-2031) & (Units)
 Figure 53. Asia-Pacific Pet Pain Reliever Revenue YoY (2020-2031) & (US$ Million)
 Figure 54. Asia-Pacific Top 8 Manufacturers Pet Pain Reliever Sales Revenue (US$ Million) in 2024
 Figure 55. Asia-Pacific Pet Pain Reliever Sales Volume (Units) by Type (2020- 2031)
 Figure 56. Asia-Pacific Pet Pain Reliever Sales Revenue (US$ Million) by Type (2020- 2031)
 Figure 57. Asia-Pacific Pet Pain Reliever Sales Volume (Units) by Application (2020-2031)
 Figure 58. Asia-Pacific Pet Pain Reliever Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 59. Indonesia Pet Pain Reliever Revenue (2020-2031) & (US$ Million)
 Figure 60. Japan Pet Pain Reliever Revenue (2020-2031) & (US$ Million)
 Figure 61. South Korea Pet Pain Reliever Revenue (2020-2031) & (US$ Million)
 Figure 62. China Taiwan Pet Pain Reliever Revenue (2020-2031) & (US$ Million)
 Figure 63. India Pet Pain Reliever Revenue (2020-2031) & (US$ Million)
 Figure 64. Central and South America Pet Pain Reliever Sales YoY (2020-2031) & (Units)
 Figure 65. Central and South America Pet Pain Reliever Revenue YoY (2020-2031) & (US$ Million)
 Figure 66. Central and South America Top 5 Manufacturers Pet Pain Reliever Sales Revenue (US$ Million) in 2024
 Figure 67. Central and South America Pet Pain Reliever Sales Volume (Units) by Type (2021-2031)
 Figure 68. Central and South America Pet Pain Reliever Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 69. Central and South America Pet Pain Reliever Sales Volume (Units) by Application (2020-2031)
 Figure 70. Central and South America Pet Pain Reliever Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 71. Brazil Pet Pain Reliever Revenue (2020-2025) & (US$ Million)
 Figure 72. Argentina Pet Pain Reliever Revenue (2020-2025) & (US$ Million)
 Figure 73. Middle East, and Africa Pet Pain Reliever Sales YoY (2020-2031) & (Units)
 Figure 74. Middle East and Africa Pet Pain Reliever Revenue YoY (2020-2031) & (US$ Million)
 Figure 75. Middle East and Africa Top 5 Manufacturers Pet Pain Reliever Sales Revenue (US$ Million) in 2024
 Figure 76. Middle East and Africa Pet Pain Reliever Sales Volume (Units) by Type (2021-2031)
 Figure 77. South America Pet Pain Reliever Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 78. Middle East and Africa Pet Pain Reliever Sales Volume (Units) by Application (2020-2031)
 Figure 79. Middle East and Africa Pet Pain Reliever Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 80. GCC Countries Pet Pain Reliever Revenue (2020-2025) & (US$ Million)
 Figure 81. Turkey Pet Pain Reliever Revenue (2020-2025) & (US$ Million)
 Figure 82. Egypt Pet Pain Reliever Revenue (2020-2025) & (US$ Million)
 Figure 83. South Africa Pet Pain Reliever Revenue (2020-2025) & (US$ Million)
 Figure 84. Pet Pain Reliever Industry Chain Mapping
 Figure 85. Regional Pet Pain Reliever Manufacturing Base Distribution (%)
 Figure 86. Global Pet Pain Reliever Production Market Share by Region (2020-2031)
 Figure 87. Pet Pain Reliever Production Process
 Figure 88. Regional Pet Pain Reliever Production Cost Structure
 Figure 89. Channels of Distribution (Direct Vs Distribution)
 Figure 90. Bottom-up and Top-down Approaches for This Report
 Figure 91. Data Triangulation
 Figure 92. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIS Group of Schools

SIMILAR REPORTS

Global Pain Relief Products Market Research Report 2024
Global Veterinary Pain Relief Market Insights Forecast to 2030
Global Painkillers For Dogs Market Research Report 2024
Global Animal Pain Medicines Market Research Report 2025
Global Pet Medicine Market Insights Forecast to 2030
Global Pets Pain Relief and Prevention Market Insights Forecast to 2030
Global Pet Allergy Relief Supplement Market Research Report 2024
Global Pet Anesthetic Drugs Market Research Report 2024
Veterinary Pain Medication Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Over The Counter OTC Pain Relievers Market Research Report 2024
Global Pet Pain Management Drugs Market Research Report 2024
Pet Tranquilizer Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Companion Animal Postoperative Pain Management Therapeutics Market Insights Forecast to 2030
Global Pain Relief Gel Market Research Report 2024
OTC Pet Medication Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Pet Rabbit Medication Market Research Report 2024
Global Pets Pain Management Market Insights Forecast to 2030
Pet Disease Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Pet Calming Treats Market Research Report 2025
Global Externally Used Pain Relief Products Market Research Report 2025
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions